Metastatic Spine Disease: Should Patients With Short Life Expectancy Be Denied Surgical Care? An International Retrospective Cohort Study

BACKGROUND: Despite our inability to accurately predict survival in many cancer patients, a life expectancy of at least 3 mo is historically necessary to be considered for surgical treatment of spinal metastases. OBJECTIVE: To compare health-related quality of life (HRQOL) in patients surviving <...

Descripción completa

Detalles Bibliográficos
Autores principales: Dea, Nicolas, Versteeg, Anne L, Sahgal, Arjun, Verlaan, Jorrit-Jan, Charest-Morin, Raphaële, Rhines, Laurence D, Sciubba, Daniel M, Schuster, James M, Weber, Michael H, Lazary, Aron, Fehlings, Michael G, Clarke, Michelle J, Arnold, Paul M, Boriani, Stefano, Bettegowda, Chetan, Laufer, Ilya, Gokaslan, Ziya L, Fisher, Charles G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Research—Human—Clinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360875/
https://www.ncbi.nlm.nih.gov/pubmed/31690935
http://dx.doi.org/10.1093/neuros/nyz472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360875/
https://www.ncbi.nlm.nih.gov/pubmed/31690935
http://dx.doi.org/10.1093/neuros/nyz472

Ejemplares similares